1. Altura BM, Altura BT, Gebrewold A, Ising H, Gunther T. Magnesium deficiency and hypertension: correlation between magnesium-deficient diets and microcirculatory changes in situ. Science. 1984;223(4642):1315-1317.
2. Choi DW, Maulucci-Gedde M, Kriegstein AR. Glutamate neurotoxicity in cortical cell culture. J Neurosci. 1987;7(2):357-368.
3. Goodman JC, Robertson CS, Grossman RG, Narayan RK. Elevation of tumor necrosis factor in head injury. J Neuroimmunol. 1990;30(2-3):213-217.
4. Kochanek PM, Nemoto EM, Melick JA, Evans RW, Burke DF. Cerebrovascular and cerebrometabolic effects of intracarotid infused platelet-activating factor in rats. J Cereb Blood Flow Metab. 1988;8(4):546-551.
5. Lyeth BG, Hayes RL. Cholinergic and opioid mediation of traumatic brain injury. J Neurotrauma. 1992;9 Suppl 2:S463-474.
6. Maxwell WL, Povlishock JT, Graham DL. A mechanistic analysis of nondisruptive axonal injury: a review. J Neurotrauma. 1997;14(7):419-440.
7. McIntosh TK, Fernyak S, Yamakami I, Faden AI. Central and systemic kappa-opioid agonists exacerbate neurobehavioral response to brain injury in rats. Am J Physiol. 1994;267(3 Pt 2):R665-672.
8. Raghupathi R, McIntosh TK. Regionally and temporally distinct patterns of induction of c-fos, c-jun and junB mRNAs following experimental brain injury in the rat. Brain Res Mol Brain Res. 1996;37(1-2):134-144.
9. Siesjo BK. Basic mechanisms of traumatic brain damage. Ann Emerg Med. 1993;22(6):959-969.
10. Kontos HA. Oxygen radicals in CNS damage. Chem Biol Interact.
1989;72(3):229-255.
11. Babior BM. Phagocytes and oxidative stress. Am J Med.
2000;109(1):33-44.
12. Ikeda Y, Long DM. The molecular basis of brain injury and brain edema: the role of oxygen free radicals. Neurosurgery. 1990;27(1):1-11.
13. Itoh T, Satou T, Nishida S, Tsubaki M, Hashimoto S, Ito H. The novel free radical scavenger, edaravone, increases neural stem cell number around the area of damage following rat traumatic brain injury. Neurotox Res. 2009;16(4):378-389.
14. Petty MA, Poulet P, Haas A, Namer IJ, Wagner J. Reduction of traumatic brain injury-induced cerebral oedema by a free radical scavenger. Eur J Pharmacol. 1996;307(2):149-155.
15. Wang GH, Jiang ZL, Li YC, et al. Free-radical scavenger edaravone treatment confers neuroprotection against traumatic brain injury in rats. J Neurotrauma. 2011;28(10):2123-2134.
16. Lapchak PA. A critical assessment of edaravone acute ischemic stroke efficacy trials: is edaravone an effective neuroprotective therapy? Expert opinion on pharmacotherapy. 2010;11(10):1753-1763.
17. Soule BP, Hyodo F, Matsumoto K, et al. The chemistry and biology of nitroxide compounds. Free Radic Biol Med. 2007;42(11):1632-1650.
18. Hahn SM, Sullivan FJ, DeLuca AM, et al. Hemodynamic effect of the nitroxide superoxide dismutase mimics. Free Radic Biol Med. 1999;27(5-6):529-535.
19. Hosoo H, Marushima A, Nagasaki Y, et al. Neurovascular Unit Protection From Cerebral Ischemia-Reperfusion Injury by Radical-Containing Nanoparticles in Mice. Stroke. 2017;48(8):2238-2247.
20. Yoshitomi T, Miyamoto D, Nagasaki Y. Design of core--shell-type nanoparticles carrying stable radicals in the core. Biomacromolecules. 2009;10(3):596-601.
21. Yoshitomi T, Suzuki R, Mamiya T, Matsui H, Hirayama A, Nagasaki
Y. pH-sensitive radical-containing-nanoparticle (RNP) for the L-band-EPR imaging of low pH circumstances. Bioconjug Chem. 2009;20(9):1792-1798.
22. Chonpathompikunlert P, Fan CH, Ozaki Y, Yoshitomi T, Yeh CK,
Nagasaki Y. Redox nanoparticle treatment protects against neurological deficit in focused ultrasound-induced intracerebral hemorrhage. Nanomedicine (Lond). 2012;7(7):1029-1043.
23. Marushima A, Suzuki K, Nagasaki Y, et al. Newly synthesized radical-containing nanoparticles enhance neuroprotection after cerebral ischemia-reperfusion injury. Neurosurgery. 2011;68(5):1418-1425; discussion 1425-1416.
24. Flierl MA, Stahel PF, Beauchamp KM, Morgan SJ, Smith WR, Shohami E. Mouse closed head injury model induced by a weight-drop device. Nat Protoc. 2009;4(9):1328-1337.
25. Marmarou A, Foda MA, van den Brink W, Campbell J, Kita H, Demetriadou K. A new model of diffuse brain injury in rats. Part I: Pathophysiology and biomechanics. J Neurosurg. 1994;80(2):291-300.
26. Khandelwal VK, Singh P, Ravingerova T, Gregory M, Gandhi H, Chaudhary M. Comparison of different osmotic therapies in a mouse model of traumatic brain injury. Pharmacological reports : PR. 2017;69(1):176-184.
27. Chen Y, Constantini S, Trembovler V, Weinstock M, Shohami E. An experimental model of closed head injury in mice: pathophysiology, histopathology, and cognitive deficits. J Neurotrauma. 1996;13(10):557-568.
28. Ji X, Peng D, Zhang Y, et al. Astaxanthin improves cognitive performance in mice following mild traumatic brain injury. Brain Res. 2017;1659:88-95.
29. Tao XG, Shi JH, Hao SY, Chen XT, Liu BY. Protective Effects of Calpain Inhibition on Neurovascular Unit Injury through Downregulating Nuclear Factor-kappaB-related Inflammation during Traumatic Brain Injury in Mice. Chin Med J (Engl). 2017;130(2):187-198.
30. Hirayama A, Okamoto T, Kimura S, et al. Kangen-karyu raises surface body temperature through oxidative stress modification. Journal of clinical biochemistry and nutrition. 2016;58(3):167-173.
31. Oowada S, Endo N, Kameya H, Shimmei M, Kotake Y. Multiple
free-radical scavenging capacity in serum. Journal of clinical biochemistry and nutrition. 2012;51(2):117-121.
32. Biemond P, Swaak AJ, van Eijk HG, Koster JF. Superoxide dependent iron release from ferritin in inflammatory diseases. Free Radic Biol Med. 1988;4(3):185-198.
33. Biemond P, van Eijk HG, Swaak AJ, Koster JF. Iron mobilization from ferritin by superoxide derived from stimulated polymorphonuclear leukocytes. Possible mechanism in inflammation diseases. J Clin Invest. 1984;73(6):1576-1579.
34. Karve IP, Taylor JM, Crack PJ. The contribution of astrocytes and microglia to traumatic brain injury. Br J Pharmacol. 2016;173(4):692-702.
35. Wang G, Zhang J, Hu X, et al. Microglia/macrophage polarization dynamics in white matter after traumatic brain injury. J Cereb Blood Flow Metab. 2013;33(12):1864-1874.
36. Burda JE, Bernstein AM, Sofroniew MV. Astrocyte roles in traumatic brain injury. Exp Neurol. 2016;275 Pt 3:305-315.
37. Mei T, Kim A, Vong LB, et al. Encapsulation of tissue plasminogen activator in pH-sensitive self-assembled antioxidant nanoparticles for ischemic stroke treatment - Synergistic effect of thrombolysis and antioxidant. Biomaterials. 2019;215:119209.
38. Feliciano CP, Tsuboi K, Suzuki K, Kimura H, Nagasaki Y. Long-term bioavailability of redox nanoparticles effectively reduces organ dysfunctions and death in whole-body irradiated mice. Biomaterials. 2017;129:68-82.
39. Lee SY, Ferrari M, Decuzzi P. Shaping nano-/micro-particles for enhanced vascular interaction in laminar flows. Nanotechnology. 2009;20(49):495101.
40. Walkey CD, Olsen JB, Guo H, Emili A, Chan WC. Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake. J Am Chem Soc. 2012;134(4):2139-2147.
論文の公開元へ
